Journal
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
Volume 28, Issue 5, Pages 783-793Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2014.08.008
Keywords
Hepatocellular carcinoma; Cancer screening; Ultrasonography; Alpha fetoprotein; Desgamma carboxy prothrombin
Categories
Ask authors/readers for more resources
When hepatocellular carcinoma presents with symptoms cure is seldom possible and death usually follows within months. However, it is possible to detect HCC early, at which stage it is curable. This requires a surveillance program. The components of such a program include: identification of the at risk population, provision of appropriate surveillance tests, and an appropriate method of determining whether the abnormalities found on screening are cancer or not. Surveillance for liver cancer meets all these criteria. Unfortunately high quality evidence showing benefit of liver cancer surveillance is lacking, but lesser quality evidence is plentiful, including several cost efficacy analyses that all show that surveillance does decrease mortality. Therefore all the continental liver disease societies and all national liver disease societies have recommended that surveillance should be undertaken. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available